SAGE-217 in major depressive disorder: A phase 3, multicenter, double-blind, randomized, placebo-controlled trial-MedSci.cn

SAGE-217 in major depressive disorder: A phase 3, multicenter, double-blind, randomized, placebo-controlled trial

Clayton, A; Lasser, R; Nandy, I; Sankoh, A; Campbell, D; Werneburg, B; Silber, C; Jonas, J; Kanes, S; Gunduz-Bruce, H

EUROPEAN PSYCHIATRY, 2020; 63 (): S24

科室
- - 订阅+
  - 更多科室
工具
服务